KMX Stock Climbs As CarMax Turnaround Story Gains Traction

CarMax Inc stocks have been trading up by 6.51 percent after robust quarterly earnings and upbeat used-car demand outlook.

Live Update At 14:03:29 EDT: On Wednesday, July 15, 2026 CarMax Inc stock [NYSE: KMX] is trending up by 6.51%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

KMX has shifted from a grind sideways to a steady climb on the chart. Over the last couple of weeks, CarMax has pushed from closes near $50–$52 into the high‑$50s, finishing the latest session around $59.36. For active traders, that is a clean, tradable trend: higher highs, higher lows, with dips getting bought around the $50–$53 zone earlier in the month.

Intraday, KMX traded in a tight band between roughly $57.50 and $59.60, holding gains throughout the session. That tells you buyers are in control and dips are being supported, not slammed.

More Breaking News

• Alibaba Stock Jumps As Cloud And AI Momentum Draw Wall Street Support
• RAM ETF Slides From Highs As Volatility Grips Chip Bulls
• SOBR Safe Stock Sinks As CWV Merger Upends Shareholders
• LHAI Stock Whipsaws As Traders Focus On Cash And Volatility

Fundamentally, CarMax just printed $8.01B in quarterly revenue and $1.31 in EPS, well ahead of Wall Street expectations. Yet margins remain thin. Net profit margin sits under 1%, and the P/E near 32.4 means traders are paying up for a turnaround, not a mature cash cow. Debt is manageable with a current ratio around 2.7, but interest coverage is low, so execution matters. For KMX, the story now is simple: momentum is bullish, but the valuation assumes that Keith Barr’s strategy actually delivers.

Why Traders Are Watching KMX Right Now

KMX is back on momentum radars for a reason. After a long stretch of choppy used‑car trends, CarMax finally dropped a quarter that cleared a low bar in a big way. Revenue grew 6.2% to $8.0B, total units rose 3.3%, and EPS landed at $1.31 versus expectations near $0.95. The stock popped about 4% in premarket and later added roughly 1.8% as traders digested the numbers.

The key twist: CarMax did this while intentionally cutting retail prices, which pressured gross profit per unit. Management at KMX is clearly choosing volume and competitiveness over short‑term margin. For traders, that trade‑off matters. If volumes keep building, operating leverage can kick in later, especially as cost cuts flow through.

New CEO Keith Barr laid out a four‑pillar roadmap: more competitive pricing, a stronger omni/digital experience, better attachment of finance and protection products, and structural SG&A reduction. We’re already seeing SG&A per unit improve 6.8%. That is early, but it is real.

The Street noticed. Stephens upgraded KMX to Overweight with a $66 target, sparking roughly a 9% surge. Baird bumped its target to $55 and called this the early stage of a turnaround. RBC, Morgan Stanley, and UBS all raised targets as well, with UBS going up to $57 while staying Neutral and warning the ride may be bumpy. That mix of optimism and caution is exactly what active traders like: enough belief to fuel rallies, enough doubt to keep short interest and volatility alive.

Layer on insider buys — Keith Barr grabbing 9,400 KMX shares and director Mark O’Neil picking up 9,600 shares — and you have leadership literally buying the turnaround story they are selling.

Conclusion

For traders, KMX is turning into a classic execution story with real volatility fuel. CarMax is growing the top line again, but it is doing it the hard way: cutting prices, taking near‑term margin pain, and betting that better digital tools and leaner SG&A will restore profitability down the road. The market has rewarded the early progress, pushing KMX from the low‑$50s into the high‑$50s and reacting strongly to every new data point, from earnings to analyst upgrades.

At the same time, CarMax is tuning its balance sheet. The company added $500M in term loans maturing in 2029 and used the cash to pay down its $2B revolver and support working capital. That move stretches out maturities and gives KMX breathing room to execute on Keith Barr’s four‑pillar plan. Being named to the 2026 Civic 50 list does not move the tape, but it rounds out the picture of a national brand with staying power.

For short‑term traders, the recent strength and tight intraday ranges make KMX a momentum and breakout watch — but the rich P/E and thin margins demand strict risk control. As Tim Sykes likes to say, “The market rewards disciplined traders who cut losses quickly and wait for the best setups.” That focus on preparation and clarity before entering a trade echoes another key trading maxim: As Tim Bohen, lead trainer with StocksToTrade says, “If you’re still guessing at the end of your analysis, it’s probably not a trade worth taking.”. With CarMax, the setup is a bullish turnaround narrative that still has to prove itself quarter by quarter. Use the volatility, respect the risk, and let the chart and the earnings do the talking.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.